MAPT and Alzheimer disease: In fact, the introduction of the “cholinergic hypothesis” of Alzheimer’s disease (AD) was based on ACh deficiency as a way to explain the excessive neuroinflammation, extracellular deposition of β-amyloid (Aβ), and irregular phosphorylation of tau protein, all of which affect cognitive function [13,14].